Assessing the impact of the Australia-United States Free Trade Agreement on Australian and global medicines policy
Download (287.84 kB)
-
Altmetric Citations
Drahos, Peter F; Searles, Andrew; Neville, Warwick; Doran, Evan; Henry, David A; Pekarsky, Brita; Faunce, Thomas
Description
On 1 January 2005, a controversial trade agreement entered into force between Australia and the United States. Though heralded by the parties as facilitating the removal of barriers to free trade (in ways not achievable in multilateral fora), it also contained many trade-restricting intellectual property provisions and others uniquely related to altering pharmaceutical regulation and public health policy in Australia. The latter appear to have particularly focused on the...[Show more]
dc.contributor.author | Drahos, Peter F | |
---|---|---|
dc.contributor.author | Searles, Andrew | |
dc.contributor.author | Neville, Warwick | |
dc.contributor.author | Doran, Evan | |
dc.contributor.author | Henry, David A | |
dc.contributor.author | Pekarsky, Brita | |
dc.contributor.author | Faunce, Thomas | |
dc.date.accessioned | 2009-04-20T05:41:10Z | |
dc.date.accessioned | 2010-12-20T06:03:05Z | |
dc.date.available | 2009-04-20T05:41:10Z | |
dc.date.available | 2010-12-20T06:03:05Z | |
dc.identifier.citation | Globalization and Health 15.1 (2005): 1-10 | |
dc.identifier.issn | 1744-8603 | |
dc.identifier.uri | http://hdl.handle.net/10440/82 | |
dc.description.abstract | On 1 January 2005, a controversial trade agreement entered into force between Australia and the United States. Though heralded by the parties as facilitating the removal of barriers to free trade (in ways not achievable in multilateral fora), it also contained many trade-restricting intellectual property provisions and others uniquely related to altering pharmaceutical regulation and public health policy in Australia. The latter appear to have particularly focused on the world-respected process of federal government reimbursement after expert cost-effectiveness evaluation, popularly known as the Pharmaceutical Benefits Scheme ('PBS'). It remains uncertain what sort of impacts – if any – the Australia-United States Free Trade Agreement ('AUSFTA') will have on PBS processes such as reference pricing and their important role in facilitating equitable and affordable access to essential medicines. This is now the field of inquiry for a major three year Australian Research Council ('ARC')-funded study bringing together a team of senior researchers in regulatory theory from the Australian National University and pharmacoeconomics from the University of Newcastle. The project proposes to monitor, assess and analyse the real and potential impacts of the AUSFTA in this area, providing Australian policy-makers with continuing expertise and options. To the extent that the AUSFTA medicines provisions may represent an important precedent in a global strategy by industry on cost-effectiveness evaluation of pharmaceuticals, the study will also be of great interest to policy makers in other jurisdictions. | |
dc.format | 10 pages | |
dc.publisher | BioMed Central | |
dc.rights | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0)which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. | |
dc.source | Globalization and Health | |
dc.source.uri | http://www.globalizationandhealth.com/content/pdf/1744-8603-1-15.pdf | |
dc.subject | Keywords: essential drug; article; Australia; cost benefit analysis; cost effectiveness analysis; drug cost; drug industry; drug legislation; drug marketing; expert system; government regulation; health care access; health care policy; international cooperation; me | |
dc.title | Assessing the impact of the Australia-United States Free Trade Agreement on Australian and global medicines policy | |
dc.type | Journal article | |
local.description.refereed | Yes | |
local.identifier.citationvolume | 15 | |
dcterms.dateAccepted | 2005-10-06 | |
dc.date.issued | 2005-10-06 | |
local.identifier.absfor | 180119 | |
local.identifier.ariespublication | MigratedxPub13995 | |
local.type.status | Published Version | |
local.contributor.affiliation | Faunce, Thomas A, ANU College of Law and Medical School | |
local.contributor.affiliation | Drahos, Peter F, Research School of Pacific and Asian Studies, Regulatory Institutions Network Program | |
local.contributor.affiliation | Searles, Andrew, Research School of Pacific and Asian Studies, Regulatory Institutions Network Program | |
local.contributor.affiliation | Neville, Warwick, Research School of Social Sciences, Philosophy Program | |
local.contributor.affiliation | Doran, Evan, University of Newcastle | |
local.contributor.affiliation | Henry, David A, University of Newcastle | |
local.contributor.affiliation | Pekarsky, Brita, University of South Australia | |
local.bibliographicCitation.issue | 1 | |
local.bibliographicCitation.startpage | 1 | |
local.bibliographicCitation.lastpage | 10 | |
local.identifier.doi | 10.1186/1744-8603-1-15 | |
dc.date.updated | 2015-12-12T08:00:19Z | |
local.identifier.scopusID | 2-s2.0-29444443468 | |
Collections | ANU Research Publications |
Download
File | Description | Size | Format | Image |
---|---|---|---|---|
Faunce_Assessing2005.pdf | 287.84 kB | Adobe PDF |
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.
Updated: 17 November 2022/ Responsible Officer: University Librarian/ Page Contact: Library Systems & Web Coordinator